Mercury General Corp
Change company Symbol lookup
Select an option...
MCY Mercury General Corp
PSPC Post Holdings Partnering Corp
RCKTF Rock Tech Lithium Inc
SOND Sonder Holdings Inc
PTE PolarityTE Inc
CTRA Coterra Energy Inc
L Loews Corp
HSY Hershey Co
ATGE Adtalem Global Education Inc
FARO FARO Technologies Inc
Go

Financials : Insurance | Small Cap Value
Company profile

Mercury General Corporation is an insurance holding company engaged in writing personal automobile insurance business. The Company writes homeowners, commercial automobile, commercial property, mechanical protection, and umbrella insurance. The Company’s automobile coverages include property damage, bodily injury, personal injury protection, underinsured, and uninsured motorist and other hazards. Its homeowners’ coverage includes dwelling, liability, personal property, fire, and other hazards. The Company offers standard, non-standard, and preferred private passenger automobile insurance. The Company also offers homeowners insurance in approximately 10 states, commercial automobile insurance in approximately four states, and mechanical protection insurance in various states. The Company’s subsidiaries include Mercury Casualty Company, California Automobile Insurance Company, Orion Indemnity Company, American Mercury Insurance Company and Mercury Insurance Company of Illinois.

Closing Price
$29.41
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,142,099
0

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

5:12 pm ET July 6, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Ocugen Inc. OCGN slid 3.08% to $2.52 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to 3,845.08 and the Dow Jones Industrial Average DJIA rising 0.23% to 31,037.68. The stock's fall snapped a four-day winning streak. Ocugen Inc. closed $15.13 below its 52-week high ($17.65), which the company reached on November 3rd.

The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 6.03% to $1.23, Ocular Therapeutix Inc. OCUL fell 1.38% to $4.28, and Kodiak Sciences Inc. KOD rose 1.49% to $8.15. Trading volume (5.2 M) remained 1.9 million below its 50-day average volume of 7.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 6, 2022.

	

(END) Dow Jones Newswires

July 06, 2022 17:12 ET (21:12 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.